Matches in Nanopublications for { ?s ?p "[Here we show that CD34+/CD38- leukemia precursors have reduced in vitro sensitivity to daunorubicin, a major drug used in leukemia treatment, in comparison with the CD34+/CD38+ counterpart, and increased expression of multidrug resistance genes (mrp/lrp).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- NP293838.RADJU019QJ87QVZmNRTrRDfB5JpZzkVosQAz_LzG2HO-c130_assertion description "[Here we show that CD34+/CD38- leukemia precursors have reduced in vitro sensitivity to daunorubicin, a major drug used in leukemia treatment, in comparison with the CD34+/CD38+ counterpart, and increased expression of multidrug resistance genes (mrp/lrp).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP293838.RADJU019QJ87QVZmNRTrRDfB5JpZzkVosQAz_LzG2HO-c130_provenance.
- NP293839.RAfdG77MKHxG_y-RM6xK7MctLpJDE8w4MAaC2VuRsLGQM130_assertion description "[Here we show that CD34+/CD38- leukemia precursors have reduced in vitro sensitivity to daunorubicin, a major drug used in leukemia treatment, in comparison with the CD34+/CD38+ counterpart, and increased expression of multidrug resistance genes (mrp/lrp).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP293839.RAfdG77MKHxG_y-RM6xK7MctLpJDE8w4MAaC2VuRsLGQM130_provenance.